Weekly Recap | PDS Biotechnology -18.12%, consensus target above spotWeekly Review·Oct 17, 2026 at 07:50 AMPDSB+29.10%
Weekly Recap | PDS Biotechnology +84.37%, surging ahead of KOL eventWeekly Review·Oct 10, 2026 at 07:24 AMPDSB+29.10%
Weekly Recap | PDS Biotechnology +173.14%, financing and board news lead the moveWeekly Review·Sep 19, 2026 at 06:31 AMPDSB+29.10%
Weekly Recap | PDS Biotechnology +34.05%, most brokers rate it buyWeekly Review·Sep 12, 2026 at 06:35 AMPDSB+29.10%
